Nicolau Syndrome after Intramuscular Injection of Non-Steroidal Anti-Inflammatory Drugs (NSAID)
Keywords:Nicolau syndrome, intramuscular injections, subcutaneous fat tissue thickness, gluteal necrosis
Nicolau syndrome is a rare complication of intramuscular injection that leads to local ischemic necrosis of the skin and adipose tissue. In this paper, we discuss etiologies, risk factors, and treatment options for gluteal Nicolau syndrome referring to patients treated in our hospital. Our study includes 17 women who visited our clinic with symptoms of gluteal necrosis secondary to intramuscular injection. The following variables were taken into account: injection site, drug administered, frequency of injections, the person who administered the injections, needle size, and needle tip color. Magnetic resonance images obtained in the aftermath of intramuscular injection application were carefully analyzed for presence of necrosis, cyst formation and the thickness of the gluteal fat tissue layer. Drugs that had been received in intramuscular injection were exclusively non-steroidal anti-inflammatory drugs. Mean patient BMI was 41.8 (all patients were considered as obese), and mean gluteal fat thickness was 54 mm. Standard length of needles (3.8 cm) had been used in procedures. The wounds were treated with primary closure in 11 patients and with local flap therapy in 6 patients. The observed necrosis was a consequence of misplaced gluteal injection, where drugs were injected into the adipose tissue instead of the muscle due to the extreme thickness of the fat layer, on one hand, and the inappropriate length of standard needles, on the other hand. Intramuscular injection should be avoided in obese patients whenever possible: if it is necessary, proper injection technique should be used.
Woo E, Chan YW, Kwong YL, Yu YL, Huang CY. A dangerous gluteal injection. J Hong Kong Medical Association. 1986;38:75-6.
Faucher L, Marcoux D. What syndrome is this? Nicolau syndrome. Pediatr Dermatol. 1995;12:187-90. http://dx.doi.org/10.1111/j.1525-1470.1995.tb00151.x
Kohler LD, Schwedler S, Worret WI. Embolia cutis medicamentosa. Int J Dermatol. 1997;36:197. http://dx.doi.org/10.1046/j.1365-4362.1997.00233.x
Greenblatt D, Divoll-Allen M. Intramuscular injection-site complications. JAMA. 1978;239:542-4. http://dx.doi.org/10.1001/jama.1978.03290060044011
Muller-Vahl H. Adverse reaction after intramuscular injections. Lancet. 1983;1:1050. http://dx.doi.org/10.1016/S0140-6736(83)92679-X
Lie C, Leung F, Chow SP. Nicolau syndrome following intramuscular diclofenac administration: a case report. J Orthop Surg. 2006;14:104-7.
Mayrink M, Mendonça AC, da Costa PR. Soft-tissue sarcoma arising from a tissue necrosis caused by an intramuscular injection of diclofenac. Plast Reconstr Surg. 2003;112:1970-1. http://dx.doi.org/10.1097/01.PRS.0000089290.92476.24
Lee DP, Bae GY, Lee MW, Choi JH, Moon KC, Koh JK. Nicolau syndrome caused by Piroxicam. Int J Dermatol. 2005;44:1069-70. http://dx.doi.org/10.1111/j.1365-4632.2004.02534.x
McGee AM, Davison PM. Skin necrosis following injection of non-steroidal antiinflammatory drug. Br J Anaesth. 2002;88:139-40. http://dx.doi.org/10.1093/bja/88.1.139
De Sousa R, Dang A, Rataboli PV. Nicolau syndrome following intramuscular benzathine penicilin. J Postgrad Med. 2008;54:332-4. http://dx.doi.org/10.4103/0022-3859.43523
Hay J. Complications at site of injection of depot neuroleptics. BMJ. 1995;311:421. http://dx.doi.org/10.1136/bmj.311.7002.421
Nagore E, Torrelo A, Gonzalez-Mediero I, Zambrano A. Livedoid skin necrosis (Nicolau syndrome) due to triple vaccine (DTP) injection. Br J Dermatol 1997;137:1030–1. http://dx.doi.org/10.1111/j.1365-2133.1997.tb01585.x
Corazza M, Capozzi O, Virgilit A. Five cases of livedo-like dermatitis (Nicolau's syndrome) due to bismuth salts and various other non-steroidal anti-inflammatory drugs. J Eur Acad Dermatol Venereol. 2001;15:585-8. http://dx.doi.org/10.1046/j.1468-3083.2001.00320.x
Kim SK, Kim TH, Lee KC. Nicolau Syndrome after intramuscular injection: 3 Cases. Arch Plast Surg. 2012;39:249-52. http://dx.doi.org/10.5999/aps.2012.39.3.249
Nisbet AC. Intramuscular gluteal injections in the increasingly obese population: retrospective study. BMJ. 2006;18:637-8. http://dx.doi.org/10.1136/bmj.38706.742731.47
Filinte GT, Akan M, Filinte D, Gonullu ME, Akoz T. Gluteal Enjeksiyonlar düşündüğümüz kadar masum mu? Olgu Sunumu. J Kartal Tıp Dergisi. 2010;21: 89-3.
McIvor A, Paluzzi M, Meguid MM. Intramuscular injection abscess-past lessons relearned. N Engl J Med. 1991;324:1897-8. http://dx.doi.org/10.1056/NEJM199106273242618